A comparative clinical trial of different subcutaneous doses of terbutaline and orciprenaline in bronchial asthma.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001986:Bronchial Spasm / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage; D008875:Middle Aged; D010627:Phenethylamines / Q000008:administration & dosage*; D011674:Pulse / Q000187:drug effects; D012118:Resorcinols / Q000008:administration & dosage*; D013147:Spirometry; D013566:Sympathomimetics / Q000008:administration & dosage*
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D013566:Sympathomimetics; D009921:Metaproterenol